Literature DB >> 23475294

The typical duration of migraine aura: a systematic review.

Michele Viana1, Till Sprenger, Michaela Andelova, Peter J Goadsby.   

Abstract

BACKGROUND: According to ICHD-II, and as proposed for ICHD-III, non-hemiplegic migraine aura (NHMA) symptoms last between five and 60 minutes whereas hemiplegic migraine aura can be longer. In ICHD-III it is proposed to label aura longer than an hour and less than a week as probable migraine with aura. We tested whether this was appropriate based on the available literature.
METHODS: We performed a systematic literature search identifying articles pertaining to a typical or prolonged duration of NHMA. We also performed a comprehensive literature search in order to identify all population-based studies or case series in which clinical features of NHMA, including but not restricted to aura duration, were reported, in order to gain a complete coverage of the available scientific data on aura duration.
RESULTS: We did not find any article exclusively focusing on the prevalence of a prolonged aura or more generally on typical NHMA duration. We found 10 articles that investigated NHMA features, including the aura duration. Five articles recorded the proportion of patients in whom whole NHMA lasted for more than one hour, which was the case in 12%-37% of patients. Six articles reported some information on the duration of single NHMA symptoms: visual aura disturbances lasting for more than one hour occurred in 6%-10% of patients, sensory aura in 14%-27% of patients and aphasic aura in 17%-60% of patients.
CONCLUSIONS: The data indicate the duration of NHMA may be longer than one hour in a significant proportion of migraineurs. This seems to be especially true for non-visual aura symptoms. The term probable seems inappropriate in ICHD-III so we propose reinstating the category of prolonged aura for patients with symptoms longer than an hour and less than one week.

Entities:  

Mesh:

Year:  2013        PMID: 23475294     DOI: 10.1177/0333102413479834

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  15 in total

Review 1.  Migraine with prolonged aura: phenotype and treatment.

Authors:  Michele Viana; Shazia Afridi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-11-16       Impact factor: 3.000

Review 2.  Our evolving understanding of migraine with aura.

Authors:  Justin M DeLange; F Michael Cutrer
Journal:  Curr Pain Headache Rep       Date:  2014-10

Review 3.  Pattern Recognition of the Multiple Sclerosis Syndrome.

Authors:  Rana K Zabad; Renee Stewart; Kathleen M Healey
Journal:  Brain Sci       Date:  2017-10-24

Review 4.  Hemiplegia and headache: a review of hemiplegia in headache disorders.

Authors:  J Ivan Lopez; Ashley Holdridge; John F Rothrock
Journal:  Curr Pain Headache Rep       Date:  2015

5.  Cortical spreading depression: origins and paths as inferred from the sequence of events during migraine aura.

Authors:  Igor Petrusic; Jasna Zidverc-Trajkovic
Journal:  Funct Neurol       Date:  2014 Jul-Sep

Review 6.  Migraine: Calcium Channels and Glia.

Authors:  Marta Kowalska; Michał Prendecki; Thomas Piekut; Wojciech Kozubski; Jolanta Dorszewska
Journal:  Int J Mol Sci       Date:  2021-03-07       Impact factor: 5.923

7.  Studies on the pathophysiology and genetic basis of migraine.

Authors:  Claudia F Gasparini; Heidi G Sutherland; Lyn R Griffiths
Journal:  Curr Genomics       Date:  2013-08       Impact factor: 2.236

8.  O011. Patients with "prolonged aura" do not show clinical or demographic differences from the patients with "typical aura".

Authors:  Michele Viana; Mattias Linde; Grazia Sances; Natascia Ghiotto; Elena Guaschino; Marta Allena; Salvatore Terrazzino; Giuseppe Nappi; Peter J Goadsby; Cristina Tassorelli
Journal:  J Headache Pain       Date:  2015-12       Impact factor: 7.277

9.  Transient localized wave patterns and their application to migraine.

Authors:  Markus A Dahlem; Thomas M Isele
Journal:  J Math Neurosci       Date:  2013-05-29       Impact factor: 1.300

10.  Prolonged acute migraine with aura and reversible brain MRI abnormalities after liquid sclerotherapy.

Authors:  Yassine Zouitina; Mathilde Terrier; Marie Hyra; Djohar Seryer; Jean-Marc Chillon; Jean-Marc Bugnicourt
Journal:  J Headache Pain       Date:  2014-06-19       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.